Frontlight ResearchEarly access
Taking peopleNo phase
Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS)
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 22 Feb 2024
- Expected to end
- 30 Sept 2028
- Type of study
- Interventional
- Treatments tested
- Patients with severe to extreme anorexia nervosa admitted to hospital for refeeding
- Record updated
- 14 November 2025
Who can take part
- Age
- 15 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Women
- Over 15 years old and 3 months
- Admitted in the specialized department for eating disorders of CHU Nantes for refeeding
- With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type)
- Body Mass Index at admission below 16 kilogram per square meter
- Written informed consent for patients over 18 years old/ oral informed consent from both the patient and a legal representative for patients under 18 years old
- Affiliated with French social security system or beneficiary from such system
Who cannot take part
- Who received a treatment with antibiotic/antifungal (other than local application) in the last three months
- Who participate in another interventional study involving medication
- Pregnant and breastfeeding women
- Who had a weight gain in the last month (5% or more of the patient's weight at admission)
- Under trusteeship or guardianship
- Not fluent in French
- Patients for whom stool collection or body mass composition analysis (with Dual-energy X-ray absorptiometry) couldn't be done during the first week of hospitalisation
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will investigate the link between the gut microbiota, the occurrence of the central adiposity phenotype, and the patients' fear to regain weight in anorexia nervosa.
The group in the trial
- Anorexia nervosaTreatment being tested
Treatment: Patients with severe to extreme anorexia nervosa admitted to hospital for refeeding
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 November 2025